Carcinoma in situ of the rectosigmoid junction is a localized form of cancer characterized by abnormal cell growth that has not invaded surrounding tissues. This condition is clinically significant as it may progress to invasive cancer if left untreated. Accurate coding with ICD-10 Code D01.1 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this condition effectively.
ICD-10 Code D01.1 represents Carcinoma in situ of the rectosigmoid junction, indicating a non-invasive cancerous condition at the junction of the rectum and sigmoid colon. This code should be used in clinical documentation and billing when a patient is diagnosed with this specific type of carcinoma, allowing for accurate tracking of cases and appropriate treatment planning.
Carcinoma in situ of the rectosigmoid junction arises from the epithelial cells at the junction of the rectum and sigmoid colon. It is often asymptomatic in early stages but can progress to invasive cancer if not detected and treated promptly. Medical attention is crucial for monitoring and intervention.
ICD-10 Code D01.1 is utilized in SOAP notes to document the diagnosis of carcinoma in situ of the rectosigmoid junction. It plays a vital role in capturing patient symptoms, assessment findings, and treatment plans, relevant in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D01.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ of the rectosigmoid junction. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Prompt treatment for carcinoma in situ of the rectosigmoid junction is essential to prevent progression to invasive cancer. Treatment typically involves surgical intervention.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D01.1 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims processing.
| CPT Code | Description |
|---|---|
| 45378 | Colonoscopy, flexible, diagnostic, including collection of specimen(s) by brushing or washing. |
| 44140 | Colectomy, partial, with anastomosis. |
| 88305 | Pathology examination of tissue, including frozen section. |
Common Questions About Using ICD-10 Code D01.1 for Carcinoma in situ of rectosigmoid junction
What are the symptoms of carcinoma in situ of the rectosigmoid junction?
Symptoms may include rectal bleeding, changes in bowel habits, and abdominal discomfort. However, many patients are asymptomatic, making regular screening important for early detection.
How is carcinoma in situ of the rectosigmoid junction treated?
Treatment typically involves surgical resection of the affected area. Regular follow-up and monitoring through colonoscopy are also essential to prevent progression to invasive cancer.
Is carcinoma in situ of the rectosigmoid junction considered cancer?
Yes, carcinoma in situ is classified as a form of cancer, albeit non-invasive. It is crucial to monitor and treat it to prevent progression to invasive cancer.
How does ICD-10 Code D01.1 affect billing?
ICD-10 Code D01.1 is used for billing purposes to indicate a diagnosis of carcinoma in situ of the rectosigmoid junction. Accurate documentation is essential for reimbursement and compliance.
Clinical Notes
SOAP notes
DAP notes
AI medical notes